Announcements
The company will publish the clinical study data of the innovation research of OBI-822/OBI-821 for metastatic breast cancer patients at the annual meeting of 2016 ASCO.
1.Date of occurrence of the event:2016/06/05 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office 4.Reciprocal shareholding ratios: N/A 5.Name …
Announcement of the Company holding investor presentation and Significant post press conference
1.Date of occurrence of the event:2016/05/30 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office 4.Reciprocal shareholding ratios: N/A 5.Name …
Company will hold the Investor Conference
1.Date of the investor conference:2016/06/05 2.Time of the investor conference:2:00 p.m.(Taiwan Time) 3.Location of the investor conference: 11F., No.97, Sec. 2, Dunhua S. Rd., Da’an Dist., Taipei City 106, Taiwan …
The company states the media’s reports on the related matters of American Society of Clinical Oncology (ASCO).
1.Date of occurrence of the event:2016/05/29 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office 4.Reciprocal shareholding ratios: N/A 5.Name …
Media reports that Michael Chang, the chairman of the company, Amy Huang, the general manager and the staffs, six people in total, were guaranteed pending summons for alleged insider trading.
1.Date of occurrence of the event:2016/05/26 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office 4.Reciprocal shareholding ratios: N/A 5.Name …
Publication of the Breast Cancer Study Abstract to be presented at ASCO 2016
1.Date of occurrence of the event:2016/05/19 2.Name of the company: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliate company”): The Company head office 4.Reciprocal shareholding …
Board Intentions to apply for long-term fund-raising plan
1.Date of the board of directors resolution:2016/05/13 2.Source of capital increase funds:The intention to issue not more than 20 million ordinary shares in domestic cash fundraising or a capital increase …
Supplementary notice on a company board resolution for the upcoming 2016 Annual Shareholders’ Meeting
1.Date of the board of directors resolution:2016/05/13 2.Date for convening the shareholders’ meeting:2016/06/27 3.Location for convening the shareholders’ meeting: Masterlink Securities Education and Training Center (Da-an District, Taipei Dun Hua …
Company reports outsider suspected of “rumor mongering” intended to manipulate company’s stock, and plans to take legal action against “NEXT Magazine”
1.Parties to the legal matter, name of the court, disposing agency, and reference/case numbers of relevant documents: Plaintiff: OBI Pharma, Inc. Defendants: (1)An individual spreading false rumors and manipulating company …
OBI Pharma announces the end of the implementation for its first treasury share buyback program
1.Originally determined ceiling on total monetary amount of the share repurchase:NTD 5,646,671,868 2.Original scheduled period for the repurchase:2016/02/25-2016/04/24 3.Originally determined number of shares to be repurchased:3,000 shares 4.Originally determined type …